Streetbeat News

Products Services

ELTX

Elicio Therapeutics has published data from its Phase 1 AMPLIFY-201 study of ELI-002 2P in solid tumors in Nature Medicine. The results show that ELI-002, as a monotherapy, induced strong and lasting T cell responses and led to tumor biomarker reduction in 84% of patients. This correlated with a median relapse-free survival of 16.3 months. A Phase 2 trial for ELI-002 in pancreatic ductal adenocarcinoma is set to begin in early 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:03 am

EMBC

Embecta Corp. has submitted a 510(k) premarket notification to the FDA for a new proprietary disposable insulin delivery system. This submission is a significant step for Embecta in expanding its product portfolio in the diabetes care market.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 11:02 am

LIXT

Lixte Biotechnology has been granted a U.S. patent (#11866444) for oxabicycloheptane prodrugs. This patent strengthens the company's intellectual property portfolio and could potentially enhance its market position by protecting its novel drug developments. The patent grant is a positive development for Lixte Biotechnology, as it may provide a competitive edge in the biotech industry and could lead to partnerships or licensing deals in the future.

Portfolio Pulse from Charles Gross

January 09, 2024 | 10:36 am

MTCH

Dating apps are increasing subscription costs and introducing premium features to boost revenues in a challenging market. Match Group (NASDAQ:MTCH) raised prices and launched new service levels, resulting in a 10% YoY revenue increase to $508 million in Q3 2023 despite a 6% decrease in Tinder's user base. The sector faces a decline in app downloads, user resistance to paid features, and the impact of the cost of living crisis on millennials.

Portfolio Pulse from Ananya Gairola

January 09, 2024 | 10:12 am

AMBA

Ambarella, Inc. (NASDAQ:AMBA) has announced two new additions to its CV3-AD family of automotive AI domain controllers at CES: the CV3-AD635 and CV3-AD655 SoCs. These new SoCs enhance the company's offerings in autonomous driving technology, with the CV3-AD635 enabling mainstream L2+ features and the CV3-AD655 supporting advanced L2+ capabilities and urban autopilot. The CV3-AD family now provides a comprehensive range of solutions for different levels of autonomous driving, boasting the broadest performance range in the industry.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 10:03 am

GSK

GSK has agreed to acquire Aiolos Bio for a $1B upfront payment, with an additional $400M contingent on achieving certain regulatory milestones. This acquisition aims to expand GSK's respiratory biologics portfolio.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 9:50 am

ZIM

ZIM Integrated Shipping Services Ltd. (NYSE: ZIM) has entered into an agreement with Hoopo Systems Ltd. to implement advanced tracking devices across its dry-van container fleet. The financial details of the deal have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 9:36 am

THCH

TH International Limited, known as Tims China and trading under the Nasdaq symbol THCH, has celebrated the opening of its 10th Popeyes restaurant in Shanghai. This event signifies a notable expansion milestone for the company's operations in China.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 9:08 am

META

NVDA

Goldman Sachs analyst Peter Oppenheimer predicts a new economic 'super cycle' driven by AI and decarbonization. The cycle differs from the one that began in the 1980s, as it won't rely on declining interest rates or globalization. AI's influence on productivity and decarbonization efforts are seen as new growth drivers. Last year, AI advancements led to significant gains for companies like Nvidia and Meta. Despite a rocky start to 2024, Wall Street is optimistic about AI's market impact. Decarbonization is also expected to stimulate economic growth as economies modernize in response to climate change. Goldman Sachs refuted AI bubble fears in 2023, projecting AI investment to reach $200 billion globally by 2025.

Portfolio Pulse from Benzinga Neuro

January 09, 2024 | 8:28 am

GOOG

INTC

LNVGF

MSFT

QCOM

Lenovo Group Ltd. has introduced the ThinkBook Plus Gen 5 Hybrid at CES 2024, a 2-in-1 laptop that runs both Microsoft's Windows and Google's Android OS. The device switches from a Windows laptop to an Android tablet when the keyboard is detached. It features Intel's Core Ultra 7 processor and Qualcomm's Snapdragon 8 Plus Gen 1 chipset, and is expected to launch in Q2 2024 for $1,999.

Portfolio Pulse from Rounak Jain

January 09, 2024 | 8:23 am